Reiss joined the lab of Prof Siddharthan Chandran & Dr Bhuvaneish Selvaraj in 2024. As a research lead, he is using human embryonic stem cells (ESCs) and inducible pluripotent stem cells (iPSCs) to generate specialised brain cells which are dysfunctional in MND (motor neurons & astrocytes). Using these stem cell technologies, Reiss is interrogating the mechanisms that underlie MND pathology and screen high value candidate drugs for MND-SMART. 

Prior to joining Reiss worked as a Postdoctoral Researcher at the University of Cambridge. At Cambridge, Reiss was a research lead in the AZA-PD Parkinson’s Disease clinical trial in the lab of Dr Caroline Williams-Gray & Prof Roger Barker. Reiss received his PhD in Neuroimmunology at the University of Edinburgh, his MSc & DIC in Immunology from Imperial College London and his BSc (Hons) in Biomedical Science from Keele University.